Case 2. Patient didn't respond to steroids or several other treatments.
"A diagnosis of photoinduced Sweet’s syndrome was made. Different treatments were prescribed (systemic corticosteroids, hydroxychloroquine and doxycycline) with no results. A second-line treatment such as dapsone was chosen. This drug interferes with the myeloperoxidase-halide system that generates oxygen intermediates so it can be used in neutrophil-mediated skin diseases such as Sweet syndrome. However, it was ineffective. The patient did not tolerate methotrexate or azathioprine. Due to the patient’s poor response to treatment, adalimumab 40 mg was started every week, with an excellent clinical response after six months. No relapses have been noted after six months of follow-up."
Click on Full Text tab to access full article. sciencedirect.com/science/a...